Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 3Leukemia 3Stomach Neoplasms 2Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Vomiting 1Substance-Related Disorders 1Solid Tumors 1Recurrence 1Pituitary Neoplasms 1Pancreatic Neoplasms 1Opioid-Related Disorders 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Follicular 1Lymphoma 1Low Anterior Resection Syndrome 1Colonic Neoplasms 1Acromegaly 1

Interventions

Dexamethasone 33Palonosetron 27Aprepitant 24Ondansetron 23Granisetron 14Calcium Dobesilate 8Therapeutics 7Olanzapine 6fosaprepitant 5dexamethasone acetate 5netupitant, palosentron drug combination 4casopitant 4Doxorubicin 4Cyclophosphamide 4Acupressure 4netupitant 3dolasetron 3Yoga 3Tropisetron 3Surveys and Questionnaires 3Radiotherapy 3Metoclopramide 3Dronabinol 3Analgesia 3ramosetron 2ginger extract 2dexamethasone 21-phosphate 2Vincristine 2Tablets 2Psychiatric Rehabilitation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Vomiting × Dosage Forms × Clear all
NCT03984214 2025-04-10

Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer

Arbeitsgemeinschaft medikamentoese Tumortherapie

Phase 3 Completed
109 enrolled
Gastrointestinal

Pancreatic Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡